Tokyo, Japan

Chiyo Sakenaga

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Seikagaku Corporation. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiyo Sakenaga. Retrieved from https://idiyas.com/inventor/chiyo-sakenaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chiyo Sakenaga

Introduction

Chiyo Sakenaga is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of ocular health through her innovative inventions. With a total of three patents to her name, Sakenaga has focused on developing agents that improve human ocular subjective symptoms.

Latest Patents

Among her latest patents is an agent for improving ocular subjective symptoms and the method thereof. This invention features hyaluronic acid that is covalently bonded to an aminoalkyl cinnamate. This unique formulation aims to enhance the comfort and well-being of individuals experiencing ocular discomfort.

Career Highlights

Chiyo Sakenaga is currently associated with Seikagaku Corporation, a company known for its dedication to advancing medical technologies. Her work at the corporation has allowed her to explore innovative solutions for ocular health, contributing to the overall mission of improving patient care.

Collaborations

Sakenaga collaborates with talented individuals such as Masamichi Yamada and Keiichiro Arai. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Chiyo Sakenaga's contributions to ocular health through her patents reflect her commitment to innovation and improvement in medical science. Her work continues to inspire advancements in the field, benefiting many individuals in need of ocular relief.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…